三、预防性治疗

更新于 2026年11月19日 版权声明
三、预防性治疗

虽然PSD 具有很高的发生率,但针对脑卒中患者是否需要预防性用药一直存在争议。Robinson等[18]对脑卒中患者预防性应用艾司西酞普兰和问题解决治疗方法观察对PSD 的预防作用,发现药物和心理治疗组均可有效降低12个月时PSD的发生率,但对患者采用意向性治疗保守分析方法并未发现问题解决办法较安慰剂有效。预防性服用盐酸舍曲林的患者与服用安慰剂患者相比,心血管并发症二次住院率显著降低。舍曲林具有抗血小板聚集和血管内皮保护功能,对有冠状动脉粥样硬化性心脏病等其他血管危险因素伴脑卒中的患者可能有额外裨益[19]。长期随访发现,在脑卒中后的前6个月,开始用去甲替林或者氟西汀进行预防性抗抑郁治疗,可提高抑郁患者或者非抑郁患者的存活率[20,21]。米氮平预防性治疗的研究也证实,对于缺血性脑卒中患者,抗抑郁剂的积极使用可显著减少PSD 发生率[22]。抗抑郁剂治疗除了具有抗抑郁作用外,还具有促进认知和神经功能恢复的作用。动物实验研究发现,在卒中早期恢复阶段,大脑皮层和海马区神经营养因子表达增高,促使突触发生和轴突萌芽均显著增加,对脑卒中康复治疗有益[2]。以上这些研究均表明抗抑郁药预防干预的时机至关重要,早期治疗使患者获益。

然而荟萃分析研究的结果则互相矛盾,Chen等[23]的荟萃分析显示,抗抑郁药显著减少PSD的发生率,尤其对缺血性脑卒中患者;而Hackett等[24]的荟萃分析提示,无证据显示抗抑郁剂可预防PSD,相反却增加了不良事件的发生风险,进而指出抗抑郁剂不应用于PSD的预防。此外,有关脑卒中后康复锻炼的Meta分析显示,脑卒中后亚急性及慢性期的锻炼可预防抑郁症状的发生,但是该预防效应随着锻炼的停止而消失[25]。

总之,PSD作为脑卒中后常见的情感障碍,必须重视其对脑卒中患者以及家庭、社会的负性影响。目前,临床上急切需要抗抑郁剂治疗和预防性治疗PSD的前瞻性大样本临床病例对照研究,以获得可靠的研究数据,促进脑卒中患者神经功能的康复,这也是脑卒中单元建设的重要组成部分,具有重要的临床意义和价值。

参考文献

[1]Hackett ML,Yapa C,Parag V,et al.Frequency of depression after stroke:a systematic review of observational studies[J].Stroke,2005,36(6):1330-1340.

[2]Loubinoux I,Kronenberg G,Endres M,et al.Post-stroke depression:mechanisms,translation and therapy[J].J Cell Mol Med,2012,16(9):1961-1969.

[3]Fruehwald S,Gatterbauer E,Rehak P,et al.Early fluoxetine treatment of post-stroke depression—a three-month double-blind placebo-controlled study with an open-label long-term follow up[J].J Neurol,2003,250(3):347-351.

[4]Paolucci S,Antonucci G,Grasso MG,et al.Post-stroke depression,antidepressant treatment and rehabilitation results.A case - control study [J].Cerebrovasc Dis,2001,12(3):264-271.

[5]Yi ZM,Liu F,Zhai SD.Fluoxetine for the prophylaxis of poststrokedepression in patients with stroke:a meta-analysis[J].Int J Clin Pract,2010,64(9):1310-1317.

[6]王少华,张志珺,郭怡菁,等.西酞普兰对脑卒中后抑郁大鼠海马齿状回5-羟色胺1A受体表达的影响[J].中国神经精神疾病杂志,2007,33(8):463-466.

[7]王刚平.西酞普兰治疗脑卒中后抑郁对照研究的Meta 分析[J].临床心身疾病杂志,2008,14(1):18-22.

[8]阳中明,蔡昌群.西酞普兰治疗脑卒中后抑郁对照研究的Meta分析[J].四川精神卫生,2009,22(1):1-4.

[9]SpallettaG,CaltagironeC.Sertralinetreatmentofpost-strokemajordepression:an open study in patients with moderate to severe symptoms[J].Funct Neurol,2003,18(4):227-232.

[10]Horvath S,Karanyi Z,Harcos P,et al.Clinical effectiveness and safety of paroxetine in post-stroke depression:results from a phase 4,open label,multicenter clinical trial with 26 weeks of follow-up[J].Orv Hetil,2006,147(50):2397-2404.

[11]Kucukalic A,Bravo-Mehmedbasic A,Kulenovic AD,et al.Venlafaxine efficacy and tolerability in the treatment of post - stroke depression[J].PsychiatrDanub,2007,19(1/2):56-60.(https://www.daowen.com)

[12]Smith D,Dempster C,Glanville J,et al.Efficacy and tolerability of venlafaxine compared with selective serotonin reuptake inhibitors and other antidepressants:a meta-analysis[J].Br J Psychiatry,2002,180(5):396-404.

[13]Lincoln NB,Flannaghan T.Cognitive behavioral psychotherapy for depression following stroke:A Randomized Controlled Trial[J].Stroke,2002,34(1):111-115.

[14]Broom field NM,Laidlaw K,Hickabottom E,et al.Post-stroke depression:the case for augmented,individually tailored cognitive behavioural therapy[J].Clin Psychol Psychother,2011,18(3):202-217.

[15]Jorge RE,Robinson RG,Tateno A,et al.Repetitive transcranial magnetic stimulation as treatment of poststroke depression:a preliminary study[J].Biol Psychiatry,2004,55(4):398-405.

[16]Currier MB,Murray GB,Welch CC.Electroconvulsive therapy for poststroke depressed geriatric patients[J].J Neuropsychiatry Clin Neurosci,1992,4(2):140-144.

[17]聂荣容,黄春华.针灸治疗脑卒中后抑郁症疗效与安全性评价[J].中国针灸,2013,33(6):460.

[18]Robinson RG,Jorge RE,Moser DJ,et al.Escitalopram and problemsolving therapy for prevention of poststroke depression:a randomized controlled trial[J].JAMA,2008,299(20):2391-2400.

[19]Rasmussen A,Lunde M,Poulsen DL,et al.A double-blind,placebocontrolled study of sertraline in the prevention of depression in stroke patients[J].Psychosomatics,2003,44(3):216-221.

[20]Robinson RG,Schultz SK,Castillo C,et al.Nortriptyline versus fluoxetine in the treatment of depression and in short-term recovery after stroke:a placebo-controlled,double-blind study[J].Am J Psychiatry,2000,157(3):351-359.

[21]Narushima K,Kosier JT,Robinson RG.Preventing poststroke depression:a 12-week double-blind randomized treatment trial and 21-month follow-up[J].J Nerv Ment Dis,2002,190(5):296-303.

[22]Ween JE.Prophylactic mirtazapine may help to prevent post - stroke depression in people with good cognitive function[J].Evid Based Ment Health,2005,8(3):74.

[23]Chen Y,Patel NC,Guo JJ,et al.Antidepressant prophylaxis for poststroke depression:a meta-analysis[J].Int Clin Psychopharmacol,2007,22(3):159-166.

[24]Hackett ML,Anderson CS,House A,et al.Interventions for preventing depression after stroke[J].Cochrane Database Syst Rev,2008,16(3):CD003689.

[25]Eng JJ,Reime B.Exercise for depressive symptoms in stroke patients:a systematic review and meta-analysis[J].Clin Rehabil,2014,28(8):731-739.

(袁勇贵)

✍AI写作